Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis—results from the TOMORROW study

Management of rheumatoid arthritis: the 2012 perspective

(2014) Hisashi Yamanaka et al.   Modern Rheumatology

The limited effects of anti-tumor necrosis factor blockade on bone health in patients with rheumatoid arthritis under the use of glucocorticoid

(2013) Tadashi Okano et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Can bone loss in rheumatoid arthritis be prevented?

(2013) M. Vis et al.   OSTEOPOROSIS INTERNATIONAL

Pathways for Bone Loss in Inflammatory Disease

(2012) Tobias Braun et al.   Current Osteoporosis Reports

Arthritis Increases the Risk for Fractures -- Results from the Women's Health Initiative

(2011) N. C. WRIGHT et al.   JOURNAL OF RHEUMATOLOGY

Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009

(2010) M Neovius et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

(2009) Patrick Garnero et al.   ARTHRITIS AND RHEUMATISM